Global Newborn Blood Screening Systems Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Newborn Blood Screening Systems market size was valued at US$ 681 million in 2024 and is forecast to a readjusted size of USD 1111 million by 2031 with a CAGR of 7.3% during review period.

Newborn blood screening systems, also known as newborn screening (NBS), are public health programs designed to identify certain disorders in newborn babies shortly after birth. These systems involve taking a few drops of blood from a baby"s heel, usually within the first 24 to 48 hours after birth, and testing it for a variety of genetic, metabolic, and developmental conditions.



The tests conducted through newborn blood screening systems can vary based on location, but they often include screenings for disorders such as phenylketonuria (PKU), congenital hypothyroidism, cystic fibrosis, sickle cell disease, and many others. Early detection of these conditions allows for early intervention and treatment, which can significantly improve the baby"s health outcomes and quality of life.



Newborn blood screening is typically mandatory or strongly recommended in many countries as part of standard newborn care. It"s an essential preventive measure aimed at early identification of potential health issues, enabling timely medical interventions that can prevent or minimize the impact of certain conditions on a child"s development.



Newborn blood screening systems include screening kits, consumables, instruments and software.

Market Drivers: Rising Prevalence of Disorders: The increasing incidence of genetic, metabolic, and congenital disorders among newborns drives the demand for comprehensive screening systems.

Government Initiatives: Government-led programs mandating newborn screening in many countries promote the adoption of screening systems, ensuring early detection and intervention for better health outcomes.

Rising Healthcare Expenditure: Increased healthcare spending, especially in developing regions, allows for better infrastructure and accessibility to screening systems and services.

Market Restrictions: Cost Constraints: High initial setup costs for screening equipment and ongoing operational expenses can limit the implementation of comprehensive newborn screening programs in certain regions or healthcare settings.

Limited Access to Advanced Technology: Some regions, especially in low-resource settings, may lack access to sophisticated screening technologies, hindering comprehensive screening programs.

Variability in Healthcare Policies: Differences in healthcare policies and regulations across regions can affect the standardization and uniformity of newborn screening programs.

This report is a detailed and comprehensive analysis for global Newborn Blood Screening Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Newborn Blood Screening Systems market size and forecasts, in consumption value ($ Million), 2020-2031

Global Newborn Blood Screening Systems market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Newborn Blood Screening Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Newborn Blood Screening Systems market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Newborn Blood Screening Systems

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Newborn Blood Screening Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Waters Corporation, Danaher, Thermo Fisher, Trivitron Healthcare, Agilent Technologies, Bio-Rad Laboratories, Zivak Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Newborn Blood Screening Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Instrument and Kits
Consumables
Software

Market segment by Application
Hospital
Independent Laboratories
Other

Market segment by players, this report covers
PerkinElmer
Waters Corporation
Danaher
Thermo Fisher
Trivitron Healthcare
Agilent Technologies
Bio-Rad Laboratories
Zivak Technologies

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Newborn Blood Screening Systems product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Newborn Blood Screening Systems, with revenue, gross margin, and global market share of Newborn Blood Screening Systems from 2020 to 2025.

Chapter 3, the Newborn Blood Screening Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Newborn Blood Screening Systems market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Blood Screening Systems.

Chapter 13, to describe Newborn Blood Screening Systems research findings and conclusion.